What you will learn:
- History of drug testing in sport
- The role of urine in sports drug testing
- The role of blood in sports drug testing
- The role of DBS in sports drug testing
Sports drug testing – The past, present and future
The role of patient (athlete) centric sampling
We will briefly describe drug testing in sport, the role of urine and blood and how dried blood samples (DBS) is playing an increasing role.
Drug testing in sport began in the 1960 when urine was the only body fluid collected. As instrument sensitivity improved, the number of substances increased and smaller concentrations needed to be detected. This resulted in very little change to the sample collection approach. Blood samples were not collected until the Olympic Games in Sydney in 2000 and it is in the last few years that DBS have been accepted.
Much work is underway to increase the scope of DBS testing. Join in the Webinar to get the fuller story.
Ideal for athletes, scientists, journalists, and anyone who is interested in how to catch sports drug cheats.
Speakers:
David Cowan
Professor Emeritus in Pharmaceutical Toxicology, King's College London
David directed the UK human sports drug testing laboratory for many years and was in charge of the drug testing at the Summer Olympic and Paralympic Games held in London in 2012. He is an enthusiastic scientist who has won many awards for his work and continues to contribute to forensic science in relation to drug misuse and the harm it causes.
Daniel Eichner
President, Sports Medicine and Research Laboratory, University of Utah
Daniel has spent the past 13 years running SMRTL that conducts forensic testing for many professional and Olympic sports as well as the Department of Defense, law enforcement and medical examiners. He has a passion for research in DBS both for forensic and clinical purposes.
Moderated by:
Neil Spooner
Founder, Spooner Bioanalytical Solutions and PCSIG
Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organisations to develop technologies and introduce them to the market. Neil also assists organisations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.
David Cowan
Professor Emeritus in Pharmaceutical Toxicology, King's College London
David directed the UK human sports drug testing laboratory for many years and was in charge of the drug testing at the Summer Olympic and Paralympic Games held in London in 2012. He is an enthusiastic scientist who has won many awards for his work and continues to contribute to forensic science in relation to drug misuse and the harm it causes.
Daniel Eichner
President, Sports Medicine and Research Laboratory, University of Utah
Daniel has spent the past 13 years running SMRTL that conducts forensic testing for many professional and Olympic sports as well as the Department of Defense, law enforcement and medical examiners. He has a passion for research in DBS both for forensic and clinical purposes.
Moderated by:
Neil Spooner
Founder, Spooner Bioanalytical Solutions and PCSIG
Neil is the Founder of Spooner Bioanalytical Solutions, helping companies to integrate biological fluid microsampling, and patient centric sampling and analysis into workflows. He also works with organisations to develop technologies and introduce them to the market. Neil also assists organisations with their understanding of emerging trends in the pharmaceutical industry and bioanalysis. Neil is a Senior Visiting Research Fellow at the University of Hertfordshire, Editor in Chief of the journal, Bioanalysis, Founder of the Patient Centric Sampling Interest Group and Co-Chair of the Reid Bioanalytical Forum. He has published over 70 peer reviewed manuscripts and delivered over 50 podium presentations.
Share this webinar